Author: Simon P. Jochems; Fernando Marcon; Beatriz F. Carniel; Mark Holloway; Elena Mitsi; Emma Smith; Jenna F. Gritzfeld; Carla Solórzano; Jesús Reiné; Sherin Pojar; Elissavet Nikolaou; Esther L. German; Angie Hyder-Wright; Helen Hill; Caz Hales; Wouter A.A de Steenhuijsen Piters; Debby Bogaert; Hugh Adler; Seher Zaidi; Victoria Connor; Jamie Rylance; Helder I. Nakaya; Daniela M. Ferreira
Title: Inflammation induced by influenza virus impairs innate control of human pneumococcal carriage Document date: 2018_6_20
ID: 4fgz09cv_7
Snippet: To test whether this was specific for LAIV infection, we measured IP-10 in nasal washes from an 102 independent cohort in which a subset of subjects had asymptomatic viral upper respiratory tract 103 infection before Spn inoculation. These comprised rhinovirus (n=12), coronavirus (n=5), respiratory 104 syncytial virus (n=2) and parainfluenzavirus (n=1) 29 . The predominant virus, rhinovirus, was 105 recently shown to associate with increased pneu.....
Document: To test whether this was specific for LAIV infection, we measured IP-10 in nasal washes from an 102 independent cohort in which a subset of subjects had asymptomatic viral upper respiratory tract 103 infection before Spn inoculation. These comprised rhinovirus (n=12), coronavirus (n=5), respiratory 104 syncytial virus (n=2) and parainfluenzavirus (n=1) 29 . The predominant virus, rhinovirus, was 105 recently shown to associate with increased pneumococcal acquisition and transmission 30 . In these 106 virus-infected subjects, levels of IP-10 were increased (Fig S2) , and baseline IP-10 levels 107 correlated with increased pneumococcal density also in this second cohort (r = 0.32, p = 0.02, Fig 108 1e ). While the correlation was modest in this validation cohort suggesting that other host and 109 environmental factors are involved, this is the first time a biomarker predicting Spn density has 110 been identified.
Search related documents:
Co phrase search for related documents- independent cohort and LAIV infection: 1
- independent cohort and second cohort: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- independent cohort and Spn density: 1
- independent cohort and spn inoculation: 1
- independent cohort and subject subset: 1
- LAIV infection and pneumococcal acquisition: 1
- LAIV infection and pneumococcal density: 1
- LAIV infection and second cohort: 1
- LAIV infection and Spn density: 1
- LAIV infection and spn inoculation: 1
- nasal wash and pneumococcal density: 1, 2, 3, 4
- nasal wash and second cohort: 1
- nasal wash and Spn density: 1
- pneumococcal density and second cohort: 1
- pneumococcal density and Spn density: 1, 2
- pneumococcal density and spn inoculation: 1, 2
- predominant virus and rhinovirus predominant virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- second cohort and spn inoculation: 1
Co phrase search for related documents, hyperlinks ordered by date